These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 35632611)

  • 41. Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs.
    Hoshino Y; Pesnicak L; Dowdell KC; Lacayo J; Dudek T; Knipe DM; Straus SE; Cohen JI
    Vaccine; 2008 Jul; 26(32):4034-40. PubMed ID: 18565628
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Enhanced protection against HSV lethal challenges in mice by immunization with a combined HSV-1 glycoprotein B:H:L gene DNAs.
    Cha SC; Kim YS; Cho JK; Cho J; Kim SY; Kang H; Cho MH; Lee HH
    Virus Res; 2002 Jun; 86(1-2):21-31. PubMed ID: 12076826
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Herpes simplex virus 1 ICP0 phosphorylation site mutants are attenuated for viral replication and impaired for explant-induced reactivation.
    Mostafa HH; Thompson TW; Kushnir AS; Haenchen SD; Bayless AM; Hilliard JG; Link MA; Pitcher LA; Loveday E; Schaffer PA; Davido DJ
    J Virol; 2011 Dec; 85(23):12631-7. PubMed ID: 21937654
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Resistance of herpes simplex virus type 1 to peptidomimetic ribonucleotide reductase inhibitors: selection and characterization of mutant isolates.
    Bonneau AM; Kibler P; White P; Bousquet C; Dansereau N; Cordingley MG
    J Virol; 1996 Feb; 70(2):787-93. PubMed ID: 8551616
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physical interaction between the herpes simplex virus type 1 exonuclease, UL12, and the DNA double-strand break-sensing MRN complex.
    Balasubramanian N; Bai P; Buchek G; Korza G; Weller SK
    J Virol; 2010 Dec; 84(24):12504-14. PubMed ID: 20943970
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Definition of herpes simplex virus helper functions for the replication of adeno-associated virus type 5.
    Stutika C; Hüser D; Weger S; Rutz N; Heßler M; Heilbronn R
    J Gen Virol; 2015 Apr; 96(Pt 4):840-850. PubMed ID: 25535322
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beta interferon and gamma interferon synergize to block viral DNA and virion synthesis in herpes simplex virus-infected cells.
    Pierce AT; DeSalvo J; Foster TP; Kosinski A; Weller SK; Halford WP
    J Gen Virol; 2005 Sep; 86(Pt 9):2421-2432. PubMed ID: 16099899
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunization with a replication-defective herpes simplex virus 2 mutant reduces herpes simplex virus 1 infection and prevents ocular disease.
    van Lint AL; Torres-Lopez E; Knipe DM
    Virology; 2007 Nov; 368(2):227-31. PubMed ID: 17915278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis.
    Strelow LI; Leib DA
    J Virol; 1995 Nov; 69(11):6779-86. PubMed ID: 7474089
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Roles of Us8A and Its Phosphorylation Mediated by Us3 in Herpes Simplex Virus 1 Pathogenesis.
    Kato A; Ando T; Oda S; Watanabe M; Koyanagi N; Arii J; Kawaguchi Y
    J Virol; 2016 Jun; 90(12):5622-5635. PubMed ID: 27030266
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phosphoregulation of a Conserved Herpesvirus Tegument Protein by a Virally Encoded Protein Kinase in Viral Pathogenicity and Potential Linkage between Its Evolution and Viral Phylogeny.
    Shibazaki M; Kato A; Takeshima K; Ito J; Suganami M; Koyanagi N; Maruzuru Y; Sato K; Kawaguchi Y
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32611749
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A replication-competent, neuronal spread-defective, live attenuated herpes simplex virus type 1 vaccine.
    Brittle EE; Wang F; Lubinski JM; Bunte RM; Friedman HM
    J Virol; 2008 Sep; 82(17):8431-41. PubMed ID: 18562543
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The pre-NH(2)-terminal domain of the herpes simplex virus 1 DNA polymerase catalytic subunit is required for efficient viral replication.
    Terrell SL; Coen DM
    J Virol; 2012 Oct; 86(20):11057-65. PubMed ID: 22875965
    [TBL] [Abstract][Full Text] [Related]  

  • 54. B-myb promoter retargeting of herpes simplex virus gamma34.5 gene-mediated virulence toward tumor and cycling cells.
    Chung RY; Saeki Y; Chiocca EA
    J Virol; 1999 Sep; 73(9):7556-64. PubMed ID: 10438845
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Herpes simplex virus replication compartments can form by coalescence of smaller compartments.
    Taylor TJ; McNamee EE; Day C; Knipe DM
    Virology; 2003 May; 309(2):232-47. PubMed ID: 12758171
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1.
    Ghiasi H; Wechsler SL; Kaiwar R; Nesburn AB; Hofman FM
    J Virol; 1995 Jan; 69(1):334-40. PubMed ID: 7983727
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ICP8 Filament Formation Is Essential for Replication Compartment Formation during Herpes Simplex Virus Infection.
    Darwish AS; Grady LM; Bai P; Weller SK
    J Virol; 2015 Dec; 90(5):2561-70. PubMed ID: 26676794
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functional order of assembly of herpes simplex virus DNA replication proteins into prereplicative site structures.
    Liptak LM; Uprichard SL; Knipe DM
    J Virol; 1996 Mar; 70(3):1759-67. PubMed ID: 8627698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of CD8+ T cells and lymphoid dendritic cells in protection from ocular herpes simplex virus 1 challenge in immunized mice.
    Matundan H; Mott KR; Ghiasi H
    J Virol; 2014 Jul; 88(14):8016-27. PubMed ID: 24807710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of herpes simplex virus gamma(1)34.5 expression and oncolysis of diffuse liver metastases by Myb34.5.
    Nakamura H; Kasuya H; Mullen JT; Yoon SS; Pawlik TM; Chandrasekhar S; Donahue JM; Chiocca EA; Chung RY; Tanabe KK
    J Clin Invest; 2002 Apr; 109(7):871-82. PubMed ID: 11927614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.